Murphy Glenn S, Szokol Joseph W, Nitsun Martin, Alspach David A, Avram Michael J, Vender Jeffery S, DeMuro Nick, Hoff William J
Department of Anesthesiology, Evanston Northwestern Healthcare, Evanston, IL 60201, USA.
J Cardiothorac Vasc Anesth. 2006 Apr;20(2):156-61. doi: 10.1053/j.jvca.2005.04.003. Epub 2006 Jan 6.
Retrograde autologous priming (RAP) is a blood conservation technique used to limit the severity of hemodilution during cardiopulmonary bypass and reduce perioperative transfusions. The aim of this investigation was to examine the safety of RAP and to determine the effect of RAP on adverse outcomes after cardiac surgery.
Retrospective cohort study.
University hospital.
Five hundred fifty-nine undergoing cardiopulmonary bypass.
Data were retrospectively collected on 2 cohorts of adult cardiac surgical patients operated on by a single surgeon. In the RAP group (n = 256), outcome data were analyzed on all subjects over a 2-year period during which RAP was used routinely. This group was compared with a similar cohort of patients undergoing cardiopulmonary bypass over a 2-year period immediately before the introduction of RAP into the clinical practice (no-RAP group, n = 287).
In-hospital mortality was not significantly different between the RAP group (2.7%) and the no-RAP group (3.8%, p = 0.636). The incidence of postoperative cardiac arrest was significantly less in the RAP group (1 patient) compared to the no-RAP group (9 patients, p = 0.040). There were no differences between the 2 groups in the incidence of several other postoperative complications, including postoperative delirium (1.6% RAP v 3.1% no RAP), heart block (1.6% RAP v 4.2% no RAP), atrial fibrillation (19.1% RAP v 22.7% no RAP), and requiring postoperative ventilation >24 hours (2.7% RAP v 5.2% no RAP).
The authors observed no evidence of any increase in adverse events in the RAP group of this retrospective cohort study, but they did observe a decrease in the incidence of postoperative cardiac arrest in the RAP group. These findings suggest that RAP is a safe technique and may have a beneficial effect on postoperative outcomes.
逆行自体预充(RAP)是一种血液保护技术,用于限制体外循环期间血液稀释的严重程度并减少围手术期输血。本研究的目的是检验RAP的安全性,并确定RAP对心脏手术后不良结局的影响。
回顾性队列研究。
大学医院。
559例接受体外循环的患者。
回顾性收集由一名外科医生实施手术的两组成年心脏手术患者的数据。在RAP组(n = 256)中,分析了在常规使用RAP的2年期间内所有受试者的结局数据。将该组与在临床实践中引入RAP之前的2年期间接受体外循环的类似患者队列(非RAP组,n = 287)进行比较。
RAP组的院内死亡率(2.7%)与非RAP组(3.8%,p = 0.636)无显著差异。与非RAP组(9例患者)相比,RAP组术后心脏骤停的发生率显著更低(1例患者,p = 0.040)。两组在其他几种术后并发症的发生率方面无差异,包括术后谵妄(RAP组为1.6%,非RAP组为3.1%)、心脏传导阻滞(RAP组为1.6%,非RAP组为4.2%)、心房颤动(RAP组为19.1%,非RAP组为22.7%)以及术后需要通气>24小时(RAP组为2.7%,非RAP组为5.2%)。
在这项回顾性队列研究中,作者未观察到RAP组不良事件有任何增加的证据,但确实观察到RAP组术后心脏骤停的发生率有所降低。这些发现表明RAP是一种安全的技术,可能对术后结局有有益影响。